Cancer Causes & Control

, Volume 14, Issue 8, pp 791–803 | Cite as

Pleural mesothelioma incidence in Europe: evidence of some deceleration in the increasing trends

  • Fabio Montanaro
  • Freddie Bray
  • Valerio Gennaro
  • Enzo Merler
  • Jerzy E. Tyczynski
  • Donald Maxwell Parkin
Article

Abstract

Objective: To summarize the geographical and temporal variations in incidence of pleural mesothelioma in Europe, using the extensive data available from European general cancer registries, and consider these in light of recent trends in asbestos extraction, use and import in European countries. Material and methods: The data were extracted from the European Cancer Incidence and Mortality database (EUROCIM). The inclusion criteria was acceptance in Volume VII of Cancer Incidence in Five Continents. Truncated age-standardized rates per 100,000 for the ages 40–74 were used to summarise recent geographical variations. Standardized rate ratios and 95% confidence intervals for the periods 1986–1990 and 1991–1995 were compared to assess geographical variations in risk. To investigate changes in the magnitude of most recent trends, regression models fitted to the latest available 10-year period (1988–1997) were compared with trends in the previous decade. Fitted rates in younger (40–64) and older adults (65–74) in the most recent period were also compared. Results: There was a great deal of geographical variation in the risk of mesothelioma, annual rates ranging from around 8 per 100,000 in Scotland, England and The Netherlands, to lower than 1 per 100,000 in Spain (0.96), Estonia (0.85), Poland (0.85) and Yugoslavia, Vojvodina (0.56) among men. The rank of the rates for women was similar to that observed for men, although rates were considerably lower. Between 1978 and 1987, rates in men significantly increased in all countries (excepting Denmark). In the following 10 years, there was a deceleration in trend, and a significant increase was detectable only in England and France. In addition, the magnitude of recent trends in younger men was generally lower than those estimated for older men, in both national and regional cancer registry settings. Conclusions: While mesothelioma incidence rates are still rising in Europe, a deceleration has started in some countries. A decrease may begin in the next few years in certain European populations considering the deceleration of observed trends in mesothelioma and asbestos exposure, as well as the recent ban on its use.

asbestos exposure cancer registration incidence rates pleural mesothelioma time trends 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    McDonald JC, McDonald AD (1996) The epidemiology of mesothelioma in historical context. Eur Resp J 9: 1932-1942.Google Scholar
  2. 2.
    McDonald JC (1985) Health implications of environmental exposure to asbestos. Environ Health Perspect 62: 319-328.Google Scholar
  3. 3.
    Gennaro V, Finkelstein MM, Ceppi M, et al. (2000) Mesothelioma and lung tumors attributable to asbestos among petroleum workers. Am J Ind Med 37: 275-282.Google Scholar
  4. 4.
    Ross D, McDonald JC (1995) Occupational and geographical factors in the epidemiology of malignant mesothelioma. Monaldi Arch Chest Dis 50: 459-463.Google Scholar
  5. 5.
    Ascoli V, Calisti R, Carnovale-Scalzo C, Nardi F (2001) Malignant pleural mesothelioma in bakers and pastry cooks. Am J Ind Med 40: 371-373.Google Scholar
  6. 6.
    Gennaro V, Ceppi M, Boffetta P, Fontana V, Perrotta A (1994) Pleural mesothelioma and asbestos exposure among Italian oil refinery workers. Scand J Work Environ Health 20: 213-215.Google Scholar
  7. 7.
    Carbone M, Rizzo P, Pass HI (1997) Simian virus 40, poliovaccines and human tumors: a review of recent developments. Oncogene 15: 1877-1888.Google Scholar
  8. 8.
    Carbone M, Rizzo P, Pass H (2000) Simian virus 40: the link with human malignant mesothelioma is well established. Anticancer Res 20: 875-878.Google Scholar
  9. 9.
    Selikoff IJ, Hammond EC, Seidmann H (1980) Latency of asbestos disease among insulation workers in the United States and Canada. Cancer 46: 2736-2740.Google Scholar
  10. 10.
    Andersson M, Olsen JH (1985) Trend and distribution of mesothelioma in Denmark. Br J Cancer 51: 699-705.Google Scholar
  11. 11.
    Karjalainen A, Pukkala E, Mattson K, Tammilehto L, Vainio H (1997) Trends in mesothelioma incidence and occupational mesotheliomas in Finland 1960-1995. Scand J Work Environ Med 23: 266-270.Google Scholar
  12. 12.
    Jarvholm B, Englund A, Albin M (1999) Pleural mesothelioma in Sweden: an analysis of the incidence according to the use of asbestos. Occup Environ Med 56: 110-113.Google Scholar
  13. 13.
    Janssen-Heijnen MLG, Damhuis RAM, Klinkhamer PJJM, Schipper RM, Coebergh J-WW (1999) Increased but low incidence and poor survival of malignant mesothelioma in the southeastern part of The Netherlands since 1970: a population based study. Eur J Cancer Prev 8: 311-314.Google Scholar
  14. 14.
    Gennaro V, Montanaro F, Lazzarotto A, Bianchelli M, Celesia MV (2000) Mesothelioma registry of the Liguria region. Incidence and occupational etiology in a high risk area. Epid Prev 24: 213-218.Google Scholar
  15. 15.
    Peto J, Hodgson JT, Matthews FE, Jones JR (1995) Continuing increase in mesothelioma mortality in Britain. Lancet 345: 535-539.Google Scholar
  16. 16.
    Peto J, Decarli A, La Vecchia C, Levi F, Negri E (1999) The European mesothelioma epidemic. Br J Cancer 79: 666-672.Google Scholar
  17. 17.
    La Vecchia C, Decarli A, Peto J, Levi F, Tomei F, Negri E (2000) An age, period and cohort analysis of pleural cancer mortality in Europe. Eur J Cancer Prev 9: 179-184.Google Scholar
  18. 18.
    Gilg Soit Ilg A, Bignon J, Valleron A-J (1998) Estimation of past and future burden of mortality from mesothelioma in France. Occup Environ Med 55: 760-765.Google Scholar
  19. 19.
    Banaei A, Auvert B, Goldberg M, Gueguen A, Luce D, Goldberg S (2000) Future trends in mortality of French men form mesothelioma. Occup Environ Med 57: 188-494.Google Scholar
  20. 20.
    Merler E, Lagazio C, Biggeri A (1999) Trends in mortality from primary pleural tumors and incidence of pleural mesothelioma in Italy: a very serious situation. Epid Prev 23: 316-326.Google Scholar
  21. 21.
    European Network of Cancer Registries (2001) Eurocim version 4.0. European incidence database V2.3, 730-entity dictionary, Lyon.Google Scholar
  22. 22.
    International Agency for Research on Cancer (1997) Cancer Incidence in Five Continents. Vol VII. Lyon: I ARC Sci Publ.Google Scholar
  23. 23.
    Archivio Regionale Toscano dei Mesoteliomi Maligni: Rapporto sulla casistica 1988-2000. Centro Stampa, Gunta Regionale, Firenze 2002.Google Scholar
  24. 24.
    Boyle P, Parkin DM (1991) Statistical methods for registries. In: Cancer Registration: Principles and Methods Vol. 95. Lyon: IARC Sci Publ., 95: 126-158.Google Scholar
  25. 25.
    StataCorp. (2003) Stata Statistical Software: Release 8.0. College Station, TX: Stata Corporation.Google Scholar
  26. 26.
    Kim HJ, Fay MP, Feuer EJ, Midthune DN (2000) Permutation Tests for Joinpoint Regression with Applications to Cancer Rates. Stat Med 19: 335-351.Google Scholar
  27. 27.
    Albin M, Magnani C, Krstev S, Rapiti E, Shefer I (1999) Asbestos and cancer: an overview of current trends in Europe. Environ Health Perspect 107(Suppl 2): 289-298.Google Scholar
  28. 28.
    Wagner JC, Sleggs CA, Merchand P (1960) Diffuse pleural mesothelioma in the Northwestern Cape Province. Br J Ind Med 17: 260-271.Google Scholar
  29. 29.
    Hodgson JT, Darnton A (2000) The quantative risks of mesothelioma and lung cancer in relation to asbestos exposure. Ann Occup Hyg 44: 565-601.Google Scholar
  30. 30.
    Smith AH, Wright CC (1996) Chrystolite asbestos is the main cause of pleural mesothelioma. Am J Indl Med 30: 252-266.Google Scholar
  31. 31.
    Meurman LO, Pukkala E, Hakama M (1994) Incidence of cancer among anthophyllite asbestos miners in Finland. Occup Environ Med 51(6): 421-425.Google Scholar
  32. 32.
    Roggli VL, Vollmer RT, Butnor KJ, Sporn TA (2002) Tremolite and mesothelioma. Ann Occup Hyg 46: 447-453.Google Scholar
  33. 33.
    Roggli VL, Sanfilippo F, Shelburne JD (1992) Mesothelioma. In: Roggli VL, Greenberg SD, Pratt PC, eds. Pathology of Asbestos-Associated Diseases. Boston, MA: Little, Brown &; Co., Ch. 5, pp. 109-165.Google Scholar
  34. 34.
    Huncharek M (2002) Non-asbestos related diffuse malignant mesothelioma. Tumori 88: 1-9.Google Scholar
  35. 35.
    Huncharek M (1995) Genetic factors in the aetiology of malignant mesothelioma. Eur J Cancer 31A: 1741-1747.Google Scholar
  36. 36.
    Bolognesi C, Filiberti R, Neri M, et al. (2002) High frequency of micronuclei in peripheral blood lymphocytes as index of susceptibility to pleural malignant mesothelioma. Cancer Res 62: 5418-5419.Google Scholar
  37. 37.
    Klein G, Powers A, Croce C (2002) Association of SV40 with human tumors. Oncogene 21: 1141-1149.Google Scholar
  38. 38.
    Strickler HD, Goedert JJ, Flemming M, et al. (1996) Simian virus 40 and pleural mesothelioma in humans. Cancer Epidemiol Biomarkers Prev 5: 473-475.Google Scholar
  39. 39.
    Mulatero C, Surentheran T, Breuer J, Rudd RM (1999) Simian virus 40 and human pleural mesothelioma. Thorax 54: 60-61.Google Scholar
  40. 40.
    Emri S, Kocagoz T, Olut A, et al. (2000) Simian virus 40 is not a cofactor in the pathogenesis of environmentally induced malignant pleural mesothelioma in Turkey. Anticancer Res 20: 891-894.Google Scholar
  41. 41.
    Hübner R, Van Marck E (2002) Reappraisal of the strong association between simian virus 40 and human malignant mesothelioma of the pleura (Belgium). Cancer Causes Control 13: 121-129.Google Scholar
  42. 42.
    Hirvonen A, Mattson K, Karjalainen A, et al. (1999) Simian virus S40 (sv40)-like DNA sequences not detectable in finnish mesothelioma patients not exposed to SV40-contaminted polio vaccines. Mol Carcinog 26(2): 93-99.Google Scholar
  43. 43.
    Cerrano PG, Jasani B, Filiberti R, et al. (2003) Simian virus 40 and malignant mesothelioma (Review). Int J Oncol 22(1): 187-194.Google Scholar
  44. 44.
    Tweedaleg. Magic Mineral to Killer Dust: Turner &; Newall and the Asbestos Hazard. Oxford University Press, 2000Google Scholar
  45. 45.
    Kazan-Allen L (2002) National asbestos bans. In: http:// www.ibas.btinternet.co.uk/index.htm.Google Scholar
  46. 46.
    Bianchi C, Giarelli L, Grandi G, Brollo A, Ramani L, Zuch C (1997) Latency periods in asbestos-related mesothelioma of the pleura. Eur J Cancer Prev 6: 162-166.Google Scholar
  47. 47.
    Damhuis RAM (2000) Trend in incidence of and mortality from mesothelioma. In: Damhuis RAM, van Dijck JAAM, Siesling S, Janssen-Heijnen MLG, eds. Lung Cancer and Mesothelioma in the Netherlands 1989-1997. Utrecht: The Netherlands Cancer Registry, pp. 12-13.Google Scholar
  48. 48.
    Spirtas R, Beebe GW, Connelly RR, et al. (1986) Recent trends in mesothelioma incidence in the United States. Am J Ind Med 9: 397-407.Google Scholar
  49. 49.
    Price B (1997) Analysis of current trends in United States mesothelioma incidence. Am J Epidemiol 145: 211-218.Google Scholar
  50. 50.
    Kjellstrom T, Smartt P (2000) Increased mesothelioma incidence in New Zealand: the asbestos-cancer epidemic has started. New Zealand Med J 113: 485-489.Google Scholar
  51. 51.
    Leigh J, Davidson P, Hendrie L, Berry D (2002) Malignant mesothelioma in Australia, 1945-2000. Am J Ind Med 41: 188-201.Google Scholar
  52. 52.
    Gorini G, Merler E, Chellini E, Crocetti E, Costantini AS (2002) Is the ratio of pleural mesothelioma mortality to pleural cancer mortality approximately unity for Italy? Considerations from the oldest regional mesothelioma register in Italy. Br J Cancer 86: 1970-1971.Google Scholar
  53. 53.
    Bruno C, Comba P, Maiozzi P, Vetrugno T (1996) Accuracy of death certification of pleural mesothelioma in Italy. Eur J Epidemiol 12: 421-423.Google Scholar
  54. 54.
    Giarelli L, Grandi G, Bianchi C (1997) Malignant mesothelioma of the pleura in the Trieste-Monfalcone area, with particular regard to shipyard workers. Med Lav 88(4): 316-320.Google Scholar
  55. 55.
    Puntoni R, Vercelli M, Merlo F, Valerio F, Santi L (1979) Mortality among shipyard workers in Genoa, Italy. Ann NY Acad Sci 330: 353-377.Google Scholar
  56. 56.
    Puntoni R, Merlo F, Borsa L, Reggiardo G, Garrone E, Ceppi M (2001) A historical cohort mortality study among shipyard workers in Genova, Italy. Am J Ind Med 40: 363-370.Google Scholar
  57. 57.
    Damhuis RAM, van Gelder T (1993) Malignant mesothelioma in the Rotterdam area, 1987-1989. Eur J Cancer 29A(10): 1478-1479.Google Scholar
  58. 58.
    Scottish Cancer Intelligence Unit (2002) Mesothelioma-key facts. Scottish Cancer Therapy Network Newslett 34: 5.Google Scholar

Copyright information

© Kluwer Academic Publishers 2003

Authors and Affiliations

  • Fabio Montanaro
    • 1
  • Freddie Bray
    • 3
  • Valerio Gennaro
    • 4
  • Enzo Merler
    • 5
  • Jerzy E. Tyczynski
    • 3
  • Donald Maxwell Parkin
    • 3
  1. 1.Mesothelioma Registry of Liguria, Unit of Environmental Epidemiology and Applied BiostatisticsNational Cancer Research Institute (IST)GenovaItaly
  2. 2.Cancer Registry of Canton Ticinoc/o Istituto Cantonale di PatologiaLocarno (CH)Switzerland
  3. 3.Unit of Descriptive EpidemiologyInternational Agency for Research on Cancer (IARC)LyonFrance
  4. 4.Mesothelioma Registry of Liguria, Unit of Environmental Epidemiology and Applied BiostatisticsNational Cancer Research Institute (IST)GenovaItaly
  5. 5.Mesothelioma Registry of VenetoOccupational Health Unit, Local Health Authority of PaduaItaly

Personalised recommendations